Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benedikt Fischer

Showing results (21-30 of 297) with videos related to

Pageof 30
Sort By:
Journal of Studies on Alcohol and Drugs|June 25, 2016
Policy Measures for Prescription Opioids and Harms: Enough to Protect Public Health? A Comment on Yanovitzky (2016) and Piper et al. (2016)Benedikt Fischer, Yoko Murphy
Addiction (Abingdon, England)|August 19, 2007
Crack use in North American cities: the neglected 'epidemic'Benedikt Fischer, Michelle Coghlan
Addiction (Abingdon, England)|March 17, 2007
Illicit opioid use in the 21st century: witnessing a paradigm shift?Benedikt Fischer, Jurgen Rehm
Harm Reduction Journal|October 22, 2008
A qualitative exploration of prescription opioid injection among street-based drug users in Toronto: behaviours, preferences and drug availabilityMichelle Firestone, Benedikt Fischer
The International Journal on Drug Policy|September 4, 2012
'Opioid drought', Canadian-style? Potential implications of the 'natural experiment' of delisting oxycontin in CanadaBenedikt Fischer, Annette Keates
Journal of Studies on Alcohol and Drugs|October 5, 2023
"Safer Drug Supply" Measures in Canada to Reduce the Drug Overdose Fatality Toll: Clarifying Concepts, Practices and Evidence Within a Public Health Intervention FrameworkBenedikt Fischer, Tessa Robinson
Pharmacoepidemiology and Drug Safety|December 29, 2023
The marked oscillatory pattern in prescription opioid utilization in Canada since 2000: Selected observations and questions for outcomes and policyBenedikt Fischer, Tessa Robinson
The New Zealand Medical Journal|June 21, 2019
The New Zealand Government Inquiry Into Mental Health And Addiction's recommendations on substance use: some reflections from the science perspectiveBenedikt Fischer, Sally Casswell
Addiction (Abingdon, England)|September 8, 2011
Nutt et al.'s harm scales for drugs--room for improvement but better policy based on science with limitations than no science at allBenedikt Fischer, Perry Kendall
Addiction (Abingdon, England)|November 23, 2007
Understanding the parameters of non-medical use of prescription drugs: moving beyond mere numbersBenedikt Fischer, Jürgen Rehm
Pageof 30

Showing results (21-30 of 297) with videos related to

Sort By:
Pageof 30
Journal of Studies on Alcohol and Drugs|June 25, 2016
Policy Measures for Prescription Opioids and Harms: Enough to Protect Public Health? A Comment on Yanovitzky (2016) and Piper et al. (2016)Benedikt Fischer, Yoko Murphy
Addiction (Abingdon, England)|August 19, 2007
Crack use in North American cities: the neglected 'epidemic'Benedikt Fischer, Michelle Coghlan
Addiction (Abingdon, England)|March 17, 2007
Illicit opioid use in the 21st century: witnessing a paradigm shift?Benedikt Fischer, Jurgen Rehm
Harm Reduction Journal|October 22, 2008
A qualitative exploration of prescription opioid injection among street-based drug users in Toronto: behaviours, preferences and drug availabilityMichelle Firestone, Benedikt Fischer
The International Journal on Drug Policy|September 4, 2012
'Opioid drought', Canadian-style? Potential implications of the 'natural experiment' of delisting oxycontin in CanadaBenedikt Fischer, Annette Keates
Journal of Studies on Alcohol and Drugs|October 5, 2023
"Safer Drug Supply" Measures in Canada to Reduce the Drug Overdose Fatality Toll: Clarifying Concepts, Practices and Evidence Within a Public Health Intervention FrameworkBenedikt Fischer, Tessa Robinson
Pharmacoepidemiology and Drug Safety|December 29, 2023
The marked oscillatory pattern in prescription opioid utilization in Canada since 2000: Selected observations and questions for outcomes and policyBenedikt Fischer, Tessa Robinson
The New Zealand Medical Journal|June 21, 2019
The New Zealand Government Inquiry Into Mental Health And Addiction's recommendations on substance use: some reflections from the science perspectiveBenedikt Fischer, Sally Casswell
Addiction (Abingdon, England)|September 8, 2011
Nutt et al.'s harm scales for drugs--room for improvement but better policy based on science with limitations than no science at allBenedikt Fischer, Perry Kendall
Addiction (Abingdon, England)|November 23, 2007
Understanding the parameters of non-medical use of prescription drugs: moving beyond mere numbersBenedikt Fischer, Jürgen Rehm
Pageof 30